Buisson A. Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? Authors' reply. Aliment Pharmacol Ther 2023;57:735-736.
PMID: 36821755